水仙环素的抗肿瘤活性及机制研究进展

Research Progress on the Anti-tumor Activity and Mechanism of Narciclasine

水仙环素(narciclasine,NCS)是从石蒜科水仙属植物水仙的鳞茎中提取出的水鬼蕉碱型生物碱,被证实对多种肿瘤细胞具有显著的抑制活性。NCS的抗肿瘤作用机制多样,通过不同途径产生抗肿瘤作用,适应了当前研发多靶点抗肿瘤药物的趋向。本文结合NCS抑制乳腺癌细胞、结肠癌细胞、胃癌细胞、黑色素瘤细胞、多形性胶质母细胞瘤细胞、口腔癌细胞和原发性渗出性淋巴瘤细胞的作用及分子机制,对NCS近年来的抗肿瘤活性及作用机制研究进行综述,旨在为将来NCS类抗肿瘤药物的研发与设计提供思路和借鉴。

Narciclasine(NCS),a hymenocallis littoralis alkaloid extracted from the bulbs of the genus Narcissus in the Lycoriaceae family,has been proven to have significant anti-tumor activity against a variety of tumor cells.The antitumor mechanisms of NCS are diverse and NCS exhibits antitumor effects through different pathways,which adapts to the current trend of developing multi-target anti-tumor drugs.This review introduces the research progress of the anti-tumor activity and mechanism of NCS in recent years based on the inhibitory effect of NCS on gastric cancer cells,oral cancer cells,polymorphous glioblastoma cells,colon cancer cells,breast cancer cells,melanoma cells and primary exudative lymphoma cells,aiming to provide ideas and references for the research and development,and design of NCS type anti-tumor drugs in the future.